ADVIA CENTAUR XP CEA ASSAY N/A 10309977

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2018-11-16 for ADVIA CENTAUR XP CEA ASSAY N/A 10309977 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[129314761] The siemens application specialist transported the sample that was frozen at -20? C to another laboratory. Additional testing performed on the second patient sample on the advia centaur xpt and the immulite 2000 platforms. (b)(6) 2018 results: advia centaur xpt: 0,47 ng/ml (mean 2 dosages); immulite 2000 xpi: > 550 ng/ml (2 dosages); the sample was diluted in immulite 2000 xpi: automatic dilution 1/10: 2307 ng/ml; automatic dilution 1/20: 2518 ng/ml. The cause for the discordant advia centaur xpt cea result is unknown. Siemens healthcare diagnostics is investigating. The instruction for use (ifu) in the interpretation of results section states: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. " the instruction for use (ifu) in the limitations section states: "warning: do not use the advia centaur cea immunoassay as a screening test for diagnosis. Note: do not interpret levels of cea as absolute evidence of the presence or the absence of malignant disease. Measurements of cea should always be used in conjunction with other diagnostic procedures, including information from the patient's clinical evaluation. The concentration of cea in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, calibration, and reagent specificity. Cea determined with different manufacturers' assays will vary depending on the method of standardization and antibody specificity. " mdr 1219913-2018-00274 and mdr 1219913-2018-00276 were filed for the same event.
Patient Sequence No: 1, Text Type: N, H10


[129314762] A false low (normal) advia centaur xpt cea result was obtained on a patient sample. The result was reported to the physician and questioned. A new sample (second sample) was obtained by the laboratory. The patient sample was tested and the result was normal. The laboratory performed manual and automatic dilutions and the results were normal. The second sample was sent to (2) support laboratories using the same alternate method for testing and the results were high. A corrected report was issued. Patient undergoing cancer treatment. Patient treatment was not altered or prescribed. There was no report of adverse health consequences due to the discordant advia centaur xp cea results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2018-00275
MDR Report Key8081205
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2018-11-16
Date of Report2018-12-07
Date of Event2018-10-31
Date Mfgr Received2018-11-21
Date Added to Maude2018-11-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP CEA ASSAY
Generic NameCEA IMMUNOASSAY
Product CodeDHX
Date Received2018-11-16
Model NumberN/A
Catalog Number10309977
Lot Number05943176
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2018-11-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.